Article
Peptide additives reprogram the lipid nanoparticle corona and enhance gene delivery in a serum-free environment for lung epithelium
2026-07-13
Abstract excerpt
Lipid nanoparticles (LNPs) have become a clinical standard for systemically-administered nucleic acid drugs and vaccines, but the LNP pipeline for locally-delivered LNP therapies remains much less mature. Local delivery in lung represents a particularly compelling application space for DNA-LNP therapeutics, as local gene therapies could support sustained epithelial recovery and functional restoration in various lu...
Topics
Open a Topic to create a Post that cites this publication.
- Animal Virus Infections Studies
- Histiocytic Disorders and Treatments
- Inhalation and Respiratory Drug Delivery
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Occupational exposure and asthma
- RNA Interference and Gene Delivery
- SARS-CoV-2 and COVID-19 Research
- Tuberous Sclerosis Complex Research
Identifiers and source
- Literature Corpus work
- 8d83fcdf-cacb-559f-b544-1f9fc9a7d7c5
- DOI
- 10.64898/2026.07.10.737795
